Mirum Pharmaceuticals, Inc.
Mirum Pharmaceuticals, Inc.（MIRM）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · MIRM · 截至 2026年6月8日
活动摘要
买入笔数
1
P-Purchase only
卖出笔数
46
近12个月
买卖比
0.02
Buy/Sell (by trades)
整体情绪
Mirum Pharmaceuticals, Inc.内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月8日
MIRM 季度内部人买卖趋势
MIRM 内幕交易卖出 · MIRM 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 8, 2026
活跃内部人
近12个月交易最活跃 · MIRM CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
MIRM 高管卖出股份 · MIRM 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Jun 1, 2026 | Peetz Christopher CHIEF EXECUTIVE OFFICER · Director | Option | 30,000 | $88K | Form 4 |
| Jun 1, 2026 | Peetz Christopher CHIEF EXECUTIVE OFFICER · Director | Sale | 2,602 | $246K | Form 4 |
| Jun 1, 2026 | Peetz Christopher CHIEF EXECUTIVE OFFICER · Director | Sale | 16,595 | $1.58M⚡ | Form 4 |
| Jun 1, 2026 | Peetz Christopher CHIEF EXECUTIVE OFFICER · Director | Sale | 6,926 | $666K | Form 4 |
| Jun 1, 2026 | Peetz Christopher CHIEF EXECUTIVE OFFICER · Director | Sale | 1,973 | $192K | Form 4 |
| Jun 1, 2026 | Peetz Christopher CHIEF EXECUTIVE OFFICER · Director | Sale | 1,021 | $100K | Form 4 |
| Jun 1, 2026 | Peetz Christopher CHIEF EXECUTIVE OFFICER · Director | Sale | 883 | $88K | Form 4 |
| May 29, 2026 | Walbert Timothy P Director | Option | 3,977 | — | Form 4 |
| May 29, 2026 | Cardon Lon Director | Option | 3,977 | — | Form 4 |
| May 29, 2026 | Ramasastry Saira Director | Option | 3,977 | — | Form 4 |
| Jun 1, 2026 | Ramasastry Saira Director | Sale | 3,977 | $398K | Form 4 |
| May 29, 2026 | Fischer Laurent Director | Option | 3,977 | — | Form 4 |
| May 15, 2026 | Ramasastry Saira Director | Option | 2,000 | $47K | Form 4 |
| May 15, 2026 | Ramasastry Saira Director | Sale | 2,000 | $219K | Form 4 |
| Apr 15, 2026 | Ramasastry Saira Director | Option | 2,000 | $47K | Form 4 |
| Apr 15, 2026 | Ramasastry Saira Director | Sale | 2,000 | $194K | Form 4 |
| Mar 15, 2026 | BJERKHOLT ERIC CHIEF FINANCIAL OFFICER | Option | 13,334 | — | Form 4 |
| Mar 16, 2026 | BJERKHOLT ERIC CHIEF FINANCIAL OFFICER | Sale | 7,287 | $670K | Form 4 |
| Mar 15, 2026 | Quan Joanne CHIEF MEDICAL OFFICER | Option | 13,334 | — | Form 4 |
| Mar 16, 2026 | Quan Joanne CHIEF MEDICAL OFFICER | Sale | 7,287 | $670K | Form 4 |
| Mar 16, 2026 | Ramasastry Saira Director | Option | 2,000 | $47K | Form 4 |
| Mar 16, 2026 | Ramasastry Saira Director | Sale | 2,000 | $182K | Form 4 |
| Mar 15, 2026 | Radovich Peter PRESIDENT AND COO | Option | 23,000 | — | Form 4 |
| Mar 16, 2026 | Radovich Peter PRESIDENT AND COO | Sale | 16,515 | $1.52M⚡ | Form 4 |
| Mar 15, 2026 | Radovich Peter PRESIDENT AND COO | Option | 7,220 | — | Form 4 |
Peetz Christopher
CHIEF EXECUTIVE OFFICER · Director
日期
Jun 1
股数
30,000
均价
$2.94
总金额
$88K
Peetz Christopher
CHIEF EXECUTIVE OFFICER · Director
日期
Jun 1
股数
2,602
均价
$94.64
总金额
$246K
Peetz Christopher
CHIEF EXECUTIVE OFFICER · Director
日期
Jun 1
股数
16,595
均价
$95.34
总金额
$1.58M ⚡
Peetz Christopher
CHIEF EXECUTIVE OFFICER · Director
日期
Jun 1
股数
6,926
均价
$96.15
总金额
$666K
Peetz Christopher
CHIEF EXECUTIVE OFFICER · Director
日期
Jun 1
股数
1,973
均价
$97.56
总金额
$192K
Peetz Christopher
CHIEF EXECUTIVE OFFICER · Director
日期
Jun 1
股数
1,021
均价
$98.20
总金额
$100K
Peetz Christopher
CHIEF EXECUTIVE OFFICER · Director
日期
Jun 1
股数
883
均价
$99.66
总金额
$88K
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 MIRM 内幕交易
MIRM 内幕交易
Mirum Pharmaceuticals, Inc.（MIRM）内幕交易数据来源于公司内部人（包括Peetz Christopher (CHIEF EXECUTIVE OFFICER · Director), Ramasastry Saira (Director), Radovich Peter (PRESIDENT AND COO)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。MIRM内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Mirum Pharmaceuticals, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
MIRM 内幕交易 · 5个问题Mirum Pharmaceuticals, Inc.（MIRM）的内部人包括高管和董事，如Peetz Christopher (CHIEF EXECUTIVE OFFICER · Director), Ramasastry Saira (Director), Radovich Peter (PRESIDENT AND COO)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026